4-Bromomethyl-2-cyanobiphenyl
CAS No. 114772-54-2
4-Bromomethyl-2-cyanobiphenyl( —— )
Catalog No. M19899 CAS No. 114772-54-2
4’-Bromomethyl-2-cyanobiphenyl is a halogenated benzonitrile used in protein-binding studies of quinoxaline angiotensin II receptor antagonists.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 46 | In Stock |
|
| 50MG | 65 | In Stock |
|
| 100MG | 96 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 216 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-Bromomethyl-2-cyanobiphenyl
-
NoteResearch use only, not for human use.
-
Brief Description4’-Bromomethyl-2-cyanobiphenyl is a halogenated benzonitrile used in protein-binding studies of quinoxaline angiotensin II receptor antagonists.
-
Description4’-Bromomethyl-2-cyanobiphenyl is a halogenated benzonitrile used in protein-binding studies of quinoxaline angiotensin II receptor antagonists.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number114772-54-2
-
Formula Weight272.14
-
Molecular FormulaC14H10BrN
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESBrCc1ccc(cc1)-c1ccccc1C#N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
ZEN-3862
ZEN-3862 is an inhibitor of BET(IC50s of 0.16 and 0.13 μM for BRD4(BD1) and BRD4(BD2) , respectively).
-
NLS PKKKRKV
NLS (PKKKRKV) is a peptide derived from the 40 tumor antigen of the great ape virus (SV40 big T antigen), which is a method to enhance the nuclear portal in the research field of gene transfer.
-
[Leu144,Arg147]-Myel...
[Leu144,Arg147]-PLP (139-151) is a mutant peptide fragment of myelin proteolipid protein (PLP), with the tryptophan and histidine at positions 144 and 147 respectively replaced by leucine and arginine. [Leu144,Arg147]-PLP (139-151) also serves as a T cell receptor (TCR) antagonist for encephalitogenic Th1 clones, blocking their activation in vitro. Furthermore, [Leu144,Arg147]-PLP (139-151) can inhibit the development of experimental autoimmune encephalomyelitis (EAE).
Cart
sales@molnova.com